Integrated Diagnostics for Early Diagnosis of Liver Disease

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisAlcoholic Liver DiseaseLiver Fibroses
Interventions
OTHER

Blood tests for Single Nucleotide Polymorphisms

This extra test would be performed on participants assessed in the specialist liver clinic. This test would require an extra 5ml of blood to be taken at the time of routine blood tests for clinical purposes.

DIAGNOSTIC_TEST

Faecal microbiome analysis

This test will be undertaken for all participants who give consent and are assessed through the new liver care pathway, in the community liver assessment clinic. All participants will be given the equipment to take a stool sample at the time of presentation at the community liver assessment clinic and asked to return the sample to the clinic. The sample will be processed to remove genetic material so the microbiome can be identified.

DIAGNOSTIC_TEST

Serum for diagnostic biomarkers

Blood samples will be taken alongside blood taken for clinical assessment. In total, an extra 5ml of blood. These samples will be used to explore novel blood biomarkers using ELISA and mass-spectroscopy techniques in the University of Manchester.

Trial Locations (1)

M13 9WL

RECRUITING

Manchester University NHS Foundation Trust, Manchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Manchester

OTHER

collaborator

University of Nottingham

OTHER

collaborator

Innovate UK

OTHER_GOV

lead

Manchester University NHS Foundation Trust

OTHER_GOV